Hasil Pencarian - Ravit Geva

  • Menampilkan 1 - 12 hasil dari 12
Perbaiki Hasil
  1. 1
    Oncologic patients’ misconceptions may impede enrollment into clinical trials: a cross-sectional study

    Oncologic patients’ misconceptions may impede enrollment into clinical trials: a cross-sectional study oleh Nethanel Asher, Ari Raphael, Ido Wolf, Sharon Pelles, Ravit Geva

    Diterbitkan 2022-01-01
    Dapatkan teks lengkap
    Artikel
    Simpan ke Daftar
    Disimpan di:
  2. 2
    Effect of cannabis on oxaliplatin-induced peripheral neuropathy among oncology patients: a retrospective analysis

    Effect of cannabis on oxaliplatin-induced peripheral neuropathy among oncology patients: a retrospective analysis oleh Barliz Waissengrin, Dan Mirelman, Sharon Pelles, Felix Bukstein, Deborah T. Blumenthal, Ido Wolf, Ravit Geva

    Diterbitkan 2021-02-01
    Dapatkan teks lengkap
    Artikel
    Simpan ke Daftar
    Disimpan di:
  3. 3
    CD24 and APC Genetic Polymorphisms in Pancreatic Cancers as Potential Biomarkers for Clinical Outcome.

    CD24 and APC Genetic Polymorphisms in Pancreatic Cancers as Potential Biomarkers for Clinical Outcome. oleh Sivan Shamai, Ilana Nabiochtchikov, Sarah Kraus, Sally Zigdon, Dina Kazanov, Michal Itzhak-Klutch, Carmit Eizner, Nadir Arber, Ravit Geva

    Diterbitkan 2015-01-01
    Dapatkan teks lengkap
    Artikel
    Simpan ke Daftar
    Disimpan di:
  4. 4
    LY2495655, an antimyostatin antibody, in pancreatic cancer: a randomized, phase 2 trial

    LY2495655, an antimyostatin antibody, in pancreatic cancer: a randomized, phase 2 trial oleh Talia Golan, Ravit Geva, Donald Richards, Srinivasan Madhusudan, Boris Kin Lin, Haofei Tiffany Wang, Richard A. Walgren, Salomon M. Stemmer

    Diterbitkan 2018-10-01
    Dapatkan teks lengkap
    Artikel
    Simpan ke Daftar
    Disimpan di:
  5. 5
    412 First-in-human phase I/IIa trial to evaluate the safety and initial clinical activity of DuoBody®-PD-L1×4–1BB (GEN1046) in patients with advanced solid tumors

    412 First-in-human phase I/IIa trial to evaluate the safety and initial clinical activity of DuoBody®-PD-L1×4–1BB (GEN1046) in patients with advanced solid tumors oleh Ignacio Melero, Emiliano Calvo, Patricia LoRusso, Ravit Geva, Elena Garralda, Eytan Ben-Ami, Corinne Maurice-Dror, Michelle Niewood, Ulf Forssmann

    Diterbitkan 2020-11-01
    Artikel
    Simpan ke Daftar
    Disimpan di:
  6. 6
    Acupuncture and Reflexology for Chemotherapy-Induced Peripheral Neuropathy in Breast Cancer

    Acupuncture and Reflexology for Chemotherapy-Induced Peripheral Neuropathy in Breast Cancer oleh Idan Ben-Horin MD, Peretz Kahan Li.AC, Larisa Ryvo MD, Moshe Inbar MD, Shahar Lev-Ari PhD, Ravit Geva MD

    Diterbitkan 2017-09-01
    Dapatkan teks lengkap
    Artikel
    Simpan ke Daftar
    Disimpan di:
  7. 7
    Modified Citrus Pectin Treatment in Non-Metastatic Biochemically Relapsed Prostate Cancer: Long-Term Results of a Prospective Phase II Study

    Modified Citrus Pectin Treatment in Non-Metastatic Biochemically Relapsed Prostate Cancer: Long-Term Results of a Prospective Phase II Study oleh Daniel Keizman, Moshe Frenkel, Avivit Peer, Eli Rosenbaum, David Sarid, Ilan Leibovitch, Roy Mano, Ofer Yossepowitch, Ido Wolf, Ravit Geva, David Margel, Keren Rouvinov, Anat Stern, Hadas Dresler, Igal Kushnir, Isaac Eliaz

    Diterbitkan 2023-08-01
    Dapatkan teks lengkap
    Artikel
    Simpan ke Daftar
    Disimpan di:
  8. 8
    Modified Citrus Pectin Treatment in Non-Metastatic Biochemically Relapsed Prostate Cancer: Results of a Prospective Phase II Study

    Modified Citrus Pectin Treatment in Non-Metastatic Biochemically Relapsed Prostate Cancer: Results of a Prospective Phase II Study oleh Daniel Keizman, Moshe Frenkel, Avivit Peer, Igal Kushnir, Eli Rosenbaum, David Sarid, Ilan Leibovitch, Roy Mano, Ofer Yossepowitch, David Margel, Ido Wolf, Ravit Geva, Hadas Dresler, Keren Rouvinov, Noa Rapoport, Isaac Eliaz

    Diterbitkan 2021-11-01
    Dapatkan teks lengkap
    Artikel
    Simpan ke Daftar
    Disimpan di:
  9. 9
    First-in-human phase I/Ib open-label dose-escalation study of GWN323 (anti-GITR) as a single agent and in combination with spartalizumab (anti-PD-1) in patients with advanced solid tumors and lymphomas

    First-in-human phase I/Ib open-label dose-escalation study of GWN323 (anti-GITR) as a single agent and in combination with spartalizumab (anti-PD-1) in patients with advanced solid... oleh Ravit Geva, Jennifer Mataraza, Osama Rahma, Jason John Luke, Philippe L Bedard, Sarina A Piha-Paul, Angad Singh, Tira J Tan, Darren WT Lim, Cinta Hierro, Toshikiko Doi, Alexander Lesokhin, Javier Otero, Lisa Nardi, Alexandros Xyrafas, Xinhui Chen

    Diterbitkan 2021-08-01
    Dapatkan teks lengkap
    Artikel
    Simpan ke Daftar
    Disimpan di:
  10. 10
    Dysglycemia in non-functioning pancreatic neuroendocrine tumors (NF-PNET): Further insights into an under recognized entity

    Dysglycemia in non-functioning pancreatic neuroendocrine tumors (NF-PNET): Further insights into an under recognized entity oleh Esther Osher, Ravit Geva, Ido Wolf, Karen Tordjman, Joseph Klausner, Yael Sofer, Erez Scapa, Oren Shibolet, Dana Ben –Ami Shor, Iddo Bar-Yishay, Nir Lubezky, Yaacov Goykhman, Guy Lahat, Oz Yakir, Sharon Pelles, Asaf Aizic, Arye Blachar, Naftali Stern, Yona Greenman

    Diterbitkan 2023-09-01
    Dapatkan teks lengkap
    Artikel
    Simpan ke Daftar
    Disimpan di:
  11. 11
    A Lymph Node Ratio Model for Prognosis of Patients with Pancreatic Neuroendocrine Tumors

    A Lymph Node Ratio Model for Prognosis of Patients with Pancreatic Neuroendocrine Tumors oleh Esther Osher, Eiman Shalabna, Joseph M. Klausner, Yona Greenman, Naftali Stern, Oren Shibolet, Erez Scapa, Oz Yakir, Dana Ben-Ami Shor, Iddo Bar-Yishay, Sivan Shamai, Yael Sofer, Nir Lubezky, Yaacov Goykhman, Guy Lahat, Ido Wolf, Sharon Pelles, Asaf Aizic, Arye Blachar, Ravit Geva

    Diterbitkan 2023-01-01
    Dapatkan teks lengkap
    Artikel
    Simpan ke Daftar
    Disimpan di:
  12. 12
    Correction to: 33rd Annual Meeting & Pre-Conference Programs of the Society for Immunotherapy of Cancer (SITC 2018)

    Correction to: 33rd Annual Meeting & Pre-Conference Programs of the Society for Immunotherapy of Cancer (SITC 2018) oleh Sneha Berry, Nicolas Giraldo, Peter Nguyen, Benjamin Green, Haiying Xu, Aleksandra Ogurtsova, Abha Soni, Farah Succaria, Daphne Wang, Charles Roberts, Julie Stein, Elizabeth Engle, Drew Pardoll, Robert Anders, Tricia Cottrell, Janis M. Taube, Ben Tran, Mark Voskoboynik, James Kuo, Yung-Lue Bang, Hyun-Cheo Chung, Myung-Ju Ahn, Sang-We Kim, Ayesh Perera, Daniel Freeman, Ikbel Achour, Raffaella Faggioni, Feng Xiao, Charles Ferte, Charlotte Lemech, Funda Meric-Bernstam, Theresa Werner, Stephen Hodi, Wells Messersmith, Nancy Lewis, Craig Talluto, Mirek Dostalek, Aiyang Tao, Sarah McWhirter, Damian Trujillo, Jason Luke, Chunxiao Xu, BoMarelli, Jin Qi, Guozhong Qin, Huakui Yu, Molly Jenkins, Kin-Ming Lo, Joern-Peter Halle, Yan Lan, Matthew Taylor, Nicholas Vogelzang, Allen Cohn, Daniel Stepan, Robert Shumaker, Corina Dutcus, Matthew Guo, Emmett Schmidt, Drew Rasco, Marcia Brose, Nicholas Vogelzang, Christopher Di Simone, Sharad Jain, Donald Richards, Carlos Encarnacion, Drew Rasco, Robert Shumaker, Corina Dutcus, Daniel Stepan, Matthew Guo, Emmett Schmidt, Matthew Taylor, Nicholas Vogelzang, Carlos Encarnacion, Allen Cohn, Christopher Di Simone, Drew Rasco, Donald Richards, Matthew Taylor, Corina Dutcus, Daniel Stepan, Robert Shumaker, Matthew Guo, Emmett Schmidt, James Mier, Jeongshin An, Yeun-yeoul Yang, Won-Hee Lee, Jinho Yang, Jong-kyu Kim, Hyun Goo Kim, Se Hyun Paek, Jun Woo Lee, Joohyun Woo, Jong Bin Kim, Hyungju Kwon, Woosung Lim, Nam Sun Paik, Yoon-Keun Kim, Byung-In Moon, Filip Janku, David Tan, Juan Martin-Liberal, Shunji Takahashi, Ravit Geva, Ayca Gucalp, Xueying Chen, Kulandayan Subramanian, Jennifer Mataraza, Jennifer Wheler, Philippe Bedard

    Diterbitkan 2019-02-01
    Dapatkan teks lengkap
    Artikel
    Simpan ke Daftar
    Disimpan di:

Alat Pencarian: